U.S., June 2 -- ClinicalTrials.gov registry received information related to the study (NCT07619144) titled 'OPTIMIZE 5.5 - Optimizing Impella 5.5 Outcomes Through Advanced Data Science' on May 21.
Brief Summary: The main goal of this observational, study is to develop a clinical decision support tool utilizing Impella 5.5 pump parameters to predict native heart recovery and prevent adverse events, by leveraging data science and real-world clinical data of cardiogenic shock patients.
Therefore, secondary objectives are essential to consolidating a retrospective longitudinal analysis of Impella 5.5 pump data alongside ICU digital health record datasets to:
1. Validate the Impella 5.5 placement signal by comparing it with ICU arterial line ...